June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Evandro de Azambuja: Real-World Evidence Supporting APT Strategy in HER2+ Breast Cancer
Jun 7, 2025, 15:34

Evandro de Azambuja: Real-World Evidence Supporting APT Strategy in HER2+ Breast Cancer

Evandro de Azambuja, BSMO President 2023-2026, shared a post on LinkedIn:

“RWE evidence supports the de-escalation APT strategy for stage I HER2+ early breast cancer.
The 5-year rwDFS rate was 95.3% (95% CI 92.7-98.1) and rwOS was 97.9% (95% CI 96.2-99.7).”

Title: Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study

Authors: Soraia Lobo-Martins, Veronique Debien, Elisa Agostinetto, Marianna Sirico, Giselle de Souza Carvalho, Flavia Jacobs, Chiara Molinelli, Renata Colombo Bonadio, Pedro Bergmann, Cristiano de Pádua Souza, Laura Testa, Marina Nishimuni, André João Rossi, Gabriel Kamei Guimarães, Michel Moreau, Ugo De Giorgi, José Bines, Armando Santoro, Donatienne Taylor, Francois P. Duhoux, Giacomo Barchiesi, Matteo Lambertini, Martine Piccart, Evandro de Azambuja

Read Full Article.

Evandro de Azambuja

More posts featuring Breast Cancer on OncoDaily.